ID   UD17_HUMAN              Reviewed;         530 AA.
AC   Q9HAW7; B8K293; O00473;
DT   11-APR-2003, integrated into UniProtKB/Swiss-Prot.
DT   23-APR-2003, sequence version 2.
DT   10-MAY-2017, entry version 139.
DE   RecName: Full=UDP-glucuronosyltransferase 1-7;
DE            Short=UDPGT 1-7;
DE            Short=UGT1*7;
DE            Short=UGT1-07;
DE            Short=UGT1.7;
DE            EC=2.4.1.17;
DE   AltName: Full=UDP-glucuronosyltransferase 1-G;
DE            Short=UGT-1G;
DE            Short=UGT1G;
DE   AltName: Full=UDP-glucuronosyltransferase 1A7;
DE   Flags: Precursor;
GN   Name=UGT1A7; Synonyms=GNT1, UGT1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND TISSUE SPECIFICITY.
RX   PubMed=9271343;
RA   Strassburg C.P., Oldhafer K., Manns M.P., Tukey R.H.;
RT   "Differential expression of the UGT1A locus in human liver, biliary,
RT   and gastric tissue: identification of UGT1A7 and UGT1A10 transcripts
RT   in extrahepatic tissue.";
RL   Mol. Pharmacol. 52:212-220(1997).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANTS LYS-129; LYS-131 AND
RP   ARG-208.
RX   PubMed=11434514; DOI=10.1097/00008571-200106000-00011;
RA   Gong Q.H., Cho J.W., Huang T., Potter C., Gholami N., Basu N.K.,
RA   Kubota S., Carvalho S., Pennington M.W., Owens I.S., Popescu N.C.;
RT   "Thirteen UDP-glucuronosyltransferase genes are encoded at the human
RT   UGT1 gene complex locus.";
RL   Pharmacogenetics 11:357-368(2001).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2), AND VARIANTS LYS-129 AND
RP   LYS-131.
RA   Guillemette C., Levesque E., Girard H., Bernard O.;
RL   Submitted (JAN-2006) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15815621; DOI=10.1038/nature03466;
RA   Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H.,
RA   Minx P., Wagner-McPherson C., Layman D., Wylie K., Sekhon M.,
RA   Becker M.C., Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E.,
RA   Kremitzki C., Oddy L., Du H., Sun H., Bradshaw-Cordum H., Ali J.,
RA   Carter J., Cordes M., Harris A., Isak A., van Brunt A., Nguyen C.,
RA   Du F., Courtney L., Kalicki J., Ozersky P., Abbott S., Armstrong J.,
RA   Belter E.A., Caruso L., Cedroni M., Cotton M., Davidson T., Desai A.,
RA   Elliott G., Erb T., Fronick C., Gaige T., Haakenson W., Haglund K.,
RA   Holmes A., Harkins R., Kim K., Kruchowski S.S., Strong C.M.,
RA   Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K.,
RA   McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C.,
RA   Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N.,
RA   Swearengen-Shahid S., Snider J., Strong J.T., Thompson J., Yoakum M.,
RA   Leonard S., Pearman C., Trani L., Radionenko M., Waligorski J.E.,
RA   Wang C., Rock S.M., Tin-Wollam A.-M., Maupin R., Latreille P.,
RA   Wendl M.C., Yang S.-P., Pohl C., Wallis J.W., Spieth J., Bieri T.A.,
RA   Berkowicz N., Nelson J.O., Osborne J., Ding L., Meyer R., Sabo A.,
RA   Shotland Y., Sinha P., Wohldmann P.E., Cook L.L., Hickenbotham M.T.,
RA   Eldred J., Williams D., Jones T.A., She X., Ciccarelli F.D.,
RA   Izaurralde E., Taylor J., Schmutz J., Myers R.M., Cox D.R., Huang X.,
RA   McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C.,
RA   Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S.,
RA   Miller W., Eichler E.E., Bork P., Suyama M., Torrents D.,
RA   Waterston R.H., Wilson R.K.;
RT   "Generation and annotation of the DNA sequences of human chromosomes 2
RT   and 4.";
RL   Nature 434:724-731(2005).
RN   [5]
RP   CATALYTIC ACTIVITY, ALTERNATIVE SPLICING, FUNCTION (ISOFORM 2), AND
RP   TISSUE SPECIFICITY.
RX   PubMed=18004212; DOI=10.1097/FPC.0b013e3282f1f118;
RA   Girard H., Levesque E., Bellemare J., Journault K., Caillier B.,
RA   Guillemette C.;
RT   "Genetic diversity at the UGT1 locus is amplified by a novel 3'
RT   alternative splicing mechanism leading to nine additional UGT1A
RT   proteins that act as regulators of glucuronidation activity.";
RL   Pharmacogenet. Genomics 17:1077-1089(2007).
RN   [6]
RP   CATALYTIC ACTIVITY, FUNCTION (ISOFORM 2), AND SUBUNIT.
RX   PubMed=20610558; DOI=10.1124/dmd.110.034835;
RA   Bellemare J., Rouleau M., Girard H., Harvey M., Guillemette C.;
RT   "Alternatively spliced products of the UGT1A gene interact with the
RT   enzymatically active proteins to inhibit glucuronosyltransferase
RT   activity in vitro.";
RL   Drug Metab. Dispos. 38:1785-1789(2010).
RN   [7]
RP   FUNCTION, AND SUBUNIT.
RX   PubMed=23360619; DOI=10.1124/dmd.112.050468;
RA   Rouleau M., Roberge J., Falardeau S.A., Villeneuve L., Guillemette C.;
RT   "The relative protein abundance of UGT1A alternative splice variants
RT   as a key determinant of glucuronidation activity in vitro.";
RL   Drug Metab. Dispos. 41:694-697(2013).
RN   [8]
RP   VARIANTS LYS-129; LYS-131 AND ARG-208, AND CHARACTERIZATION OF
RP   ALLELES.
RX   PubMed=11037804; DOI=10.1097/00008571-200010000-00006;
RA   Guillemette C., Ritter J.K., Auyeung D.J., Kessler F.K., Housman D.E.;
RT   "Structural heterogeneity at the UDP-glucuronosyltransferase 1 locus:
RT   functional consequences of three novel missense mutations in the human
RT   UGT1A7 gene.";
RL   Pharmacogenetics 10:629-644(2000).
RN   [9]
RP   VARIANTS LYS-129; LYS-131 AND ARG-208.
RX   PubMed=19204906; DOI=10.1002/humu.20946;
RA   Menard V., Girard H., Harvey M., Perusse L., Guillemette C.;
RT   "Analysis of inherited genetic variations at the UGT1 locus in the
RT   French-Canadian population.";
RL   Hum. Mutat. 30:677-687(2009).
CC   -!- FUNCTION: UDPGT is of major importance in the conjugation and
CC       subsequent elimination of potentially toxic xenobiotics and
CC       endogenous compounds. Isoform 2 lacks transferase activity but
CC       acts as a negative regulator of isoform 1.
CC       {ECO:0000269|PubMed:23360619}.
CC   -!- CATALYTIC ACTIVITY: UDP-glucuronate + acceptor = UDP + acceptor
CC       beta-D-glucuronoside. {ECO:0000269|PubMed:18004212,
CC       ECO:0000269|PubMed:20610558}.
CC   -!- SUBUNIT: Isoform 1 interacts with isoform 2/i2 suggesting that
CC       oligomerization is involved in negative regulation of transferase
CC       activity by isoform 2. Isoform 1 also interacts with respective i2
CC       isoforms of UGT1A1, UGT1A3, UGT1A4, UGT1A6, UGT1A8, UGT1A9 and
CC       UGT1A10. {ECO:0000269|PubMed:20610558,
CC       ECO:0000269|PubMed:23360619}.
CC   -!- SUBCELLULAR LOCATION: Microsome. Endoplasmic reticulum membrane
CC       {ECO:0000305}; Single-pass membrane protein {ECO:0000305}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1; Synonyms=i1;
CC         IsoId=Q9HAW7-1; Sequence=Displayed;
CC       Name=2; Synonyms=i2, UGT1A7s;
CC         IsoId=Q9HAW7-2; Sequence=VSP_053963;
CC   -!- TISSUE SPECIFICITY: Liver and gastric tissue. Isoform 1 and
CC       isoform 2 are expressed in esophagus. Neither isoform is expressed
CC       in liver, kidney, colon and small intestine (PubMed:18004212).
CC       {ECO:0000269|PubMed:18004212, ECO:0000269|PubMed:9271343}.
CC   -!- POLYMORPHISM: There are four common allelic UGT1A7 variants which
CC       exhibit significant differences in catalytic activity towards 3-,
CC       7-, and 9-hydroxy-benzo(a)pyrene. UGT1A7*3 exhibits a 5.8-fold
CC       lower relative Vmax compared to UGT1A7*1, whereas UGT1A7*2 and
CC       UGT1A7*4 have a 2.6- and 2.8-fold lower relative Vmax than
CC       UGT1A7*1, respectively, suggesting that these mutations confer
CC       slow glucuronidation phenotype. {ECO:0000269|PubMed:11037804}.
CC   -!- MISCELLANEOUS: The gene is part of the UGT1A complex locus which
CC       displays alternative use of promoters, first exons and terminal
CC       exons. The locus is defined by 13 first exons, which are
CC       alternatively spliced to 3 other common exons and 2 alternative
CC       terminal exons 5. From the 27 possible mRNA isoforms, 9 produce
CC       functionally active polypeptides (UGT1A1, 1A3, 1A4, 1A5, 1A6, 1A7,
CC       1A8, 1A9 and 1A10) called isoforms 1 (i1). Use of an alternative
CC       exon 5 (5b) as terminal exon is leading to 9 additional
CC       alternatively spliced products termed isoforms i2 and which lack
CC       transferase activity.
CC   -!- SIMILARITY: Belongs to the UDP-glycosyltransferase family.
CC       {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; U89507; AAB81536.1; -; mRNA.
DR   EMBL; AF297093; AAG30419.1; -; Genomic_DNA.
DR   EMBL; DQ383513; ABD42926.1; -; mRNA.
DR   EMBL; AC006985; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC114812; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   CCDS; CCDS2506.1; -. [Q9HAW7-1]
DR   RefSeq; NP_061950.2; NM_019077.2. [Q9HAW7-1]
DR   UniGene; Hs.554822; -.
DR   ProteinModelPortal; Q9HAW7; -.
DR   BioGrid; 120055; 2.
DR   IntAct; Q9HAW7; 8.
DR   STRING; 9606.ENSP00000362525; -.
DR   BindingDB; Q9HAW7; -.
DR   ChEMBL; CHEMBL1743317; -.
DR   DrugBank; DB00688; Mycophenolate mofetil.
DR   DrugBank; DB01024; Mycophenolic acid.
DR   DrugBank; DB00197; Troglitazone.
DR   CAZy; GT1; Glycosyltransferase Family 1.
DR   iPTMnet; Q9HAW7; -.
DR   PhosphoSitePlus; Q9HAW7; -.
DR   BioMuta; UGT1A7; -.
DR   DMDM; 30173486; -.
DR   MaxQB; Q9HAW7; -.
DR   PaxDb; Q9HAW7; -.
DR   PeptideAtlas; Q9HAW7; -.
DR   PRIDE; Q9HAW7; -.
DR   DNASU; 54577; -.
DR   Ensembl; ENST00000373426; ENSP00000362525; ENSG00000244122. [Q9HAW7-1]
DR   GeneID; 54577; -.
DR   KEGG; hsa:54577; -.
DR   UCSC; uc002vut.4; human. [Q9HAW7-1]
DR   CTD; 54577; -.
DR   DisGeNET; 54577; -.
DR   GeneCards; UGT1A7; -.
DR   HGNC; HGNC:12539; UGT1A7.
DR   MIM; 191740; gene.
DR   MIM; 606432; gene.
DR   neXtProt; NX_Q9HAW7; -.
DR   OpenTargets; ENSG00000244122; -.
DR   PharmGKB; PA37182; -.
DR   eggNOG; KOG1192; Eukaryota.
DR   eggNOG; COG1819; LUCA.
DR   GeneTree; ENSGT00760000118949; -.
DR   HOGENOM; HOG000220832; -.
DR   HOVERGEN; HBG004033; -.
DR   InParanoid; Q9HAW7; -.
DR   KO; K00699; -.
DR   OMA; CEFAVEH; -.
DR   OrthoDB; EOG091G06JC; -.
DR   PhylomeDB; Q9HAW7; -.
DR   TreeFam; TF315472; -.
DR   BRENDA; 2.4.1.17; 2681.
DR   Reactome; R-HSA-156588; Glucuronidation.
DR   SABIO-RK; Q9HAW7; -.
DR   GeneWiki; UGT1A7_(gene); -.
DR   GenomeRNAi; 54577; -.
DR   PRO; PR:Q9HAW7; -.
DR   Proteomes; UP000005640; Chromosome 2.
DR   Bgee; ENSG00000244122; -.
DR   ExpressionAtlas; Q9HAW7; baseline and differential.
DR   Genevisible; Q9HAW7; HS.
DR   GO; GO:0005783; C:endoplasmic reticulum; IDA:UniProtKB.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; NAS:BHF-UCL.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0008144; F:drug binding; IDA:BHF-UCL.
DR   GO; GO:0019899; F:enzyme binding; IPI:BHF-UCL.
DR   GO; GO:0004857; F:enzyme inhibitor activity; IDA:BHF-UCL.
DR   GO; GO:0015020; F:glucuronosyltransferase activity; IDA:BHF-UCL.
DR   GO; GO:0046982; F:protein heterodimerization activity; IDA:UniProtKB.
DR   GO; GO:0042803; F:protein homodimerization activity; IDA:UniProtKB.
DR   GO; GO:0005080; F:protein kinase C binding; IDA:BHF-UCL.
DR   GO; GO:0001972; F:retinoic acid binding; IDA:BHF-UCL.
DR   GO; GO:0052695; P:cellular glucuronidation; IDA:BHF-UCL.
DR   GO; GO:0009804; P:coumarin metabolic process; IC:BHF-UCL.
DR   GO; GO:0017144; P:drug metabolic process; IDA:BHF-UCL.
DR   GO; GO:0007588; P:excretion; IC:BHF-UCL.
DR   GO; GO:0006631; P:fatty acid metabolic process; IDA:BHF-UCL.
DR   GO; GO:0051552; P:flavone metabolic process; IC:BHF-UCL.
DR   GO; GO:0052696; P:flavonoid glucuronidation; IDA:BHF-UCL.
DR   GO; GO:2001030; P:negative regulation of cellular glucuronidation; IDA:UniProtKB.
DR   GO; GO:0045922; P:negative regulation of fatty acid metabolic process; IDA:BHF-UCL.
DR   GO; GO:1904224; P:negative regulation of glucuronosyltransferase activity; IDA:BHF-UCL.
DR   GO; GO:0042573; P:retinoic acid metabolic process; IC:BHF-UCL.
DR   GO; GO:0052697; P:xenobiotic glucuronidation; IDA:BHF-UCL.
DR   InterPro; IPR002213; UDP_glucos_trans.
DR   PANTHER; PTHR11926; PTHR11926; 1.
DR   Pfam; PF00201; UDPGT; 1.
DR   PROSITE; PS00375; UDPGT; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Complete proteome; Endoplasmic reticulum;
KW   Glycoprotein; Glycosyltransferase; Membrane; Microsome; Polymorphism;
KW   Reference proteome; Signal; Transferase; Transmembrane;
KW   Transmembrane helix.
FT   SIGNAL        1     25       {ECO:0000255}.
FT   CHAIN        26    530       UDP-glucuronosyltransferase 1-7.
FT                                /FTId=PRO_0000036006.
FT   TRANSMEM    488    504       Helical. {ECO:0000255}.
FT   CARBOHYD     71     71       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    292    292       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    344    344       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   VAR_SEQ     432    530       SYKENIMRLSSLHKDRPVEPLDLAVFWVEFVMRHKGAPHLR
FT                                PAAHDLTWYQYHSLDVIGFLLAVVLTVAFITFKCCAYGYRK
FT                                CLGKKGRVKKAHKSKTH -> RKKQQSGRQM (in
FT                                isoform 2). {ECO:0000303|Ref.3}.
FT                                /FTId=VSP_053963.
FT   VARIANT     129    129       N -> K (in allele UGT1A7*2 and allele
FT                                UGT1A7*3; dbSNP:rs17868323).
FT                                {ECO:0000269|PubMed:11037804,
FT                                ECO:0000269|PubMed:11434514,
FT                                ECO:0000269|PubMed:19204906,
FT                                ECO:0000269|Ref.3}.
FT                                /FTId=VAR_015556.
FT   VARIANT     131    131       R -> K (in allele UGT1A7*2 and allele
FT                                UGT1A7*3; dbSNP:rs386656364).
FT                                {ECO:0000269|PubMed:11037804,
FT                                ECO:0000269|PubMed:11434514,
FT                                ECO:0000269|PubMed:19204906,
FT                                ECO:0000269|Ref.3}.
FT                                /FTId=VAR_015557.
FT   VARIANT     131    131       R -> Q (in dbSNP:rs17868324).
FT                                /FTId=VAR_052462.
FT   VARIANT     208    208       W -> R (in allele UGT1A7*3 and allele
FT                                UGT1A7*4; dbSNP:rs11692021).
FT                                {ECO:0000269|PubMed:11037804,
FT                                ECO:0000269|PubMed:11434514,
FT                                ECO:0000269|PubMed:19204906}.
FT                                /FTId=VAR_015558.
FT   CONFLICT    412    412       V -> A (in Ref. 1; AAB81536).
FT                                {ECO:0000305}.
FT   CONFLICT    433    433       Y -> F (in Ref. 1; AAB81536).
FT                                {ECO:0000305}.
SQ   SEQUENCE   530 AA;  59819 MW;  7D759A382AE871D3 CRC64;
     MARAGWTGLL PLYVCLLLTC GFAKAGKLLV VPMDGSHWFT MQSVVEKLIL RGHEVVVVMP
     EVSWQLGRSL NCTVKTYSTS YTLEDQDREF MVFADARWTA PLRSAFSLLT SSSNGIFDLF
     FSNCRSLFND RKLVEYLKES CFDAVFLDPF DACGLIVAKY FSLPSVVFAR GIFCHYLEEG
     AQCPAPLSYV PRLLLGFSDA MTFKERVWNH IMHLEEHLFC PYFFKNVLEI ASEILQTPVT
     AYDLYSHTSI WLLRTDFVLE YPKPVMPNMI FIGGINCHQG KPVPMEFEAY INASGEHGIV
     VFSLGSMVSE IPEKKAMAIA DALGKIPQTV LWRYTGTRPS NLANNTILVK WLPQNDLLGH
     PMTRAFITHA GSHGVYESIC NGVPMVMMPL FGDQMDNAKR METKGAGVTL NVLEMTSEDL
     ENALKAVIND KSYKENIMRL SSLHKDRPVE PLDLAVFWVE FVMRHKGAPH LRPAAHDLTW
     YQYHSLDVIG FLLAVVLTVA FITFKCCAYG YRKCLGKKGR VKKAHKSKTH
//
